Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.

A series of 3,3-disubstituted pyrrolidine monoamine triple reuptake inhibitors were discovered. Analogues with low nanomolar potency, good human in vitro microsomal stability and in vitro permeability, and low drug-drug interaction potential are described. One example showed in vivo anti-depressant-like effects in the mouse tail suspension assay with a minimum effective dose of 30 mg/kg i.p.

[1]  M. Ogasawara,et al.  Rhodium-catalyzed asymmetric 1,4-addition of organoboron reagents to 5,6-dihydro-2(1H)-pyridinones. Asymmetric synthesis of 4-aryl-2-piperidinones. , 2001, The Journal of organic chemistry.

[2]  G. Blackburn-Munro,et al.  Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain , 2005, Psychopharmacology.

[3]  M. Thase,et al.  Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs , 2008, Biological Psychiatry.

[4]  N. Miyaura,et al.  Rhodium-Catalyzed Conjugate Addition of Aryl- or 1-Alkenylboronic Acids to Enones , 1997 .

[5]  B. E. Rossiter,et al.  Asymmetric conjugate addition , 1992 .

[6]  B. Lebowitz,et al.  Medication augmentation after the failure of SSRIs for depression. , 2006, The New England journal of medicine.

[7]  N. Miyaura,et al.  Rhodium(I)-Catalyzed Asymmetric 1,4-Addition of Arylboronic Acids to α,β-Unsaturated Amides , 2001 .

[8]  Tamio Hayashi,et al.  Rhodium-catalyzed asymmetric 1,4-addition and its related asymmetric reactions. , 2003, Chemical reviews.

[9]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[10]  H. Reichmann,et al.  Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease , 2006, Journal of the Neurological Sciences.

[11]  P. Czobor,et al.  Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor. , 2006, CNS drug reviews.

[12]  Wei-Liang Duan,et al.  Rhodium-catalyzed asymmetric construction of quaternary carbon stereocenters: ligand-dependent regiocontrol in the 1,4-addition to substituted maleimides. , 2006, Journal of the American Chemical Society.

[13]  M. Lucas,et al.  Microwave-enhanced rhodium-catalyzed conjugate-addition of aryl boronic acids to unprotected maleimides , 2007 .

[14]  M. Ogasawara,et al.  Catalytic cycle of rhodium-catalyzed asymmetric 1,4-addition of organoboronic acids. Arylrhodium, oxa-pi-allylrhodium, and hydroxorhodium intermediates. , 2002, Journal of the American Chemical Society.

[15]  M. Lautens,et al.  Rhodium-catalyzed carbon-carbon bond forming reactions of organometallic compounds. , 2003, Chemical reviews.

[16]  B. Thierry,et al.  The tail suspension test: A new method for screening antidepressants in mice , 2004, Psychopharmacology.

[17]  Heikkila Re,et al.  Pharmacological basis of therapeutics: dopamine receptors. , 1984 .